
Opinion|Videos|December 19, 2024
Advantages of the molecular structure of aflibercept
Panelists discuss how aflibercept’s molecular structure contributes to its clinical efficacy as a standard treatment for retinal vascular diseases.
Advertisement
Episodes in this series

Video content above is prompted by the following:
- Aflibercept 2 mg is considered the standard of care for retinal vascular diseases. Can you briefly explain the structure of the aflibercept molecule and its significance?
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Modern Retina
1
Retina World Congress 2026: Identifying real-world durability gaps in wet AMD treatment
2
Retina World Congress 2026: Rethinking macular hole surgery without gas tamponade
3
Retina World Congress 2026: Diagnosing macular telangiectasia in a field of mimickers
4
Retina World Congress 2026: The case for earlier surgical intervention in diabetic macular edema
5






















